Clinical Trials Insight: 700044732

Trial Profile

Clinical Trials Insight: 700044732

Phase of Trial: Phase III

Latest Information Update: 20 May 2009

At a glance

  • Drugs Iloperidone; Risperidone
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Adverse reactions
  • Sponsors Vanda Pharmaceuticals
  • Most Recent Events

    • 20 May 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top